Innmedics Global Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 5 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 72.84%
(FY 2022)
- Profit 357.62%
(FY 2022)
- Ebitda 371.21%
(FY 2022)
- Net Worth 335.37%
(FY 2022)
- Total Assets 47.52%
(FY 2022)
About Innmedics Global Pharma
The Company is engaged in the Jewelry & Fashion Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jigar Mehta and Manan Mehta serve as directors at the Company.
- CIN/LLPIN
U33300GJ2020PTC111835
- Company No.
111835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2020
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innmedics Global Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigar Mehta  | Managing Director | 02-Jan-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manan Mehta | Director | 02-Jan-2020 | Current |
Financial Performance of Innmedics Global Pharma.
Innmedics Global Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.84% increase. The company also saw a substantial improvement in profitability, with a 357.62% increase in profit. The company's net worth Soared by an impressive increase of 335.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innmedics Global Pharma?
Unlock access to Innmedics Global Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avron Hospitals Private LimitedActive 7 years 8 monthsJigar Mehta and Manan Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innmedics Global Pharma?
Unlock and access historical data on people associated with Innmedics Global Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innmedics Global Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innmedics Global Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
